| Systematic transcriptomic and phenotypic characterization of human and murine cardiac myocyte cell lines and primary cardiomyocytes reveals serious limitations and low … Z Onódi, T Visnovitz, B Kiss, S Hambalkó, A Koncz, B Ágg, B Váradi, ... Journal of Molecular and Cellular Cardiology 165, 19-30, 2022 | 67 | 2022 |
| Characterization of immune checkpoint inhibitor‐induced cardiotoxicity reveals interleukin‐17A as a driver of cardiac dysfunction after anti‐PD‐1 treatment TG Gergely, D Kucsera, VE Tóth, T Kovács, NV Sayour, ZD Drobni, ... British Journal of Pharmacology 180 (6), 740-761, 2022 | 24 | 2022 |
| Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion GB Brenner, A Makkos, CT Nagy, Z Onódi, NV Sayour, TG Gergely, B Kiss, ... Cells 9 (3), 551, 2020 | 21 | 2020 |
| Post-myocardial infarction heart failure in closed-chest coronary occlusion/reperfusion model in Göttingen Minipigs and Landrace pigs GB Brenner, Z Giricz, R Garamvölgyi, A Makkos, Z Onódi, NV Sayour, ... JoVE (Journal of Visualized Experiments), e61901, 2021 | 16 | 2021 |
| Cardioprotective efficacy of limb remote ischaemic preconditioning in rats: discrepancy between a meta-analysis and a three-centre in vivo study NV Sayour, GB Brenner, A Makkos, B Kiss, C Kovácsházi, TG Gergely, ... Cardiovascular Research 119 (6), 1336-1351, 2023 | 8 | 2023 |
| IL-1β neutralization prevents diastolic dysfunction development, but lacks hepatoprotective effect in an aged mouse model of NASH D Kucsera, VE Tóth, NV Sayour, T Kovács, TG Gergely, M Ruppert, ... Scientific Reports 13 (1), 356, 2023 | 7 | 2023 |
| Saxagliptin Cardiotoxicity in Chronic Heart Failure: The Role of DPP4 in the Regulation of Neuropeptide Tone I Vörös, Z Onódi, VÉ Tóth, TG Gergely, É Sághy, A Görbe, Á Kemény, ... Biomedicines 10 (7), 1573, 2022 | 7 | 2022 |
| Rosiglitazone Does Not Show Major Hidden Cardiotoxicity in Models of Ischemia/Reperfusion but Abolishes Ischemic Preconditioning-Induced Antiarrhythmic Effects in Rats In Vivo BY Weber, GB Brenner, B Kiss, TG Gergely, NV Sayour, H Tian, A Makkos, ... Pharmaceuticals 15 (9), 1055, 2022 | 5 | 2022 |
| Immune checkpoints in cardiac physiology and pathology: therapeutic targets for heart failure TG Gergely, ZD Drobni, M Kallikourdis, H Zhu, WC Meijers, TG Neilan, ... Nature Reviews Cardiology, 1-20, 2024 | 4 | 2024 |
| Droplet Digital PCR Is a Novel Screening Method Identifying Potential Cardiac G-Protein-Coupled Receptors as Candidate Pharmacological Targets in a Rat Model of Pressure … NV Sayour, VÉ Tóth, RN Nagy, I Vörös, TG Gergely, Z Onódi, N Nagy, ... International Journal of Molecular Sciences 24 (18), 13826, 2023 | 2 | 2023 |
| Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors TG Gergely, ZD Drobni, NV Sayour, P Ferdinandy, ZV Varga Basic Research in Cardiology, 1-19, 2024 | | 2024 |
| Effect of hypercholesterolemia on circulating and cardiomyocyte-derived extracellular vesicles C Kovácsházi, S Hambalkó, NV Sayour, TG Gergely, GB Brenner, ... Scientific Reports 14 (1), 12016, 2024 | | 2024 |
| The changes in the pharmacotherapy of heart failure with reduced ejection fraction and its effect on prognosis: experience in the Hungarian clinical practice B Muk, D Pilecky, F Bánfi-Bacsárdi, T Füzesi, GT Gergely, A Komáromi, ... Orvosi hetilap 165 (18), 698-710, 2024 | | 2024 |
| Effects of Bempedoic Acid in Acute Myocardial Infarction in Rats: No Cardioprotection and No Hidden Cardiotoxicity TG Gergely, GB Brenner, RN Nagy, NV Sayour, A Makkos, C Kovácsházi, ... International Journal of Molecular Sciences 24 (2), 1585, 2023 | | 2023 |
